NIR-II bioimaging of small molecule fluorophores: From basic research to clinical applications
C Li, X Guan, X Zhang, D Zhou, S Son, Y Xu… - Biosensors and …, 2022 - Elsevier
Due to the low autofluorescence and deep-photo penetration, the second near-infrared
region fluorescence imaging technology (NIR-II, 1000–2000 nm) has been widely utilized in …
region fluorescence imaging technology (NIR-II, 1000–2000 nm) has been widely utilized in …
Multimorbidity, frailty and diabetes in older people–identifying interrelationships and outcomes
AJ Sinclair, AH Abdelhafiz - Journal of personalized medicine, 2022 - mdpi.com
Multimorbidity and frailty are highly prevalent in older people with diabetes. This high
prevalence is likely due to a combination of ageing and diabetes-related complications and …
prevalence is likely due to a combination of ageing and diabetes-related complications and …
Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
R McQueenie, HME Foster, BD Jani, SV Katikireddi… - PloS one, 2020 - journals.plos.org
Background It is now well recognised that the risk of severe COVID-19 increases with some
long-term conditions (LTCs). However, prior research primarily focuses on individual LTCs …
long-term conditions (LTCs). However, prior research primarily focuses on individual LTCs …
Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies
Background Cohorts such as UK Biobank are increasingly used to study multimorbidity;
however, there are concerns that lack of representativeness may lead to biased results. This …
however, there are concerns that lack of representativeness may lead to biased results. This …
An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes
Background Frailty and multimorbidity are common in type 2 diabetes (T2D), including
people< 65 years. Guidelines recommend adjustment of treatment targets in people with …
people< 65 years. Guidelines recommend adjustment of treatment targets in people with …
Multimorbidity and catastrophic health expenditure among patients with diabetes in China: a nationwide population-based study
Y Fu, M Chen, L Si - BMJ Global Health, 2022 - gh.bmj.com
Introduction Multimorbidity is common among patients with diabetes and can lead to
catastrophic health expenditure (CHE) for their families. This study aims to investigate the …
catastrophic health expenditure (CHE) for their families. This study aims to investigate the …
Estimating and characterizing the burden of multimorbidity in the community: A comprehensive multistep analysis of two large nationwide representative surveys in …
J Coste, JM Valderas, L Carcaillon-Bentata - PLoS Medicine, 2021 - journals.plos.org
Background Given the increasing burden of chronic conditions, multimorbidity is now a
priority for healthcare and public health systems worldwide. Appropriate methodological …
priority for healthcare and public health systems worldwide. Appropriate methodological …
Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings
Background Chronic kidney disease (CKD) typically co-exists with multimorbidity (presence
of 2 or more long-term conditions: LTCs). The associations between CKD, multimorbidity …
of 2 or more long-term conditions: LTCs). The associations between CKD, multimorbidity …
The relationship between high-density lipoprotein cholesterol (HDL-C) and glycosylated hemoglobin in diabetic patients aged 20 or above: a cross-sectional study
R Huang, L Yan, Y Lei - BMC endocrine disorders, 2021 - Springer
Aim The incidence rate of diabetes is increasing year by year, seriously threatening human
health. As a predictor of glycemic control, glycated hemoglobin is reported to be related to …
health. As a predictor of glycemic control, glycated hemoglobin is reported to be related to …
Diabetes complication burden and patterns and risk of mortality in people with schizophrenia and diabetes: a population-based cohort study with 16-year follow-up
Schizophrenia is associated with increased prevalence of diabetes. However, risk of
diabetes complications as well as the impact of complication burden and patterns on …
diabetes complications as well as the impact of complication burden and patterns on …